09955881 · Active · incorporated 10 years, 9 months ago · Abingdon
Biotech Biotech & Life Sciences Drug Discovery Series B+
Develops T-cell vaccines and immunotherapies for viral and infectious diseases using ligandome screening.
Gylden Pharma Limited is a private limited company registered at Companies House under number 09955881, incorporated on 18 January 2016, with a registered office in Abingdon, Oxfordshire. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 120 filings for this company, including 11 funding rounds. Its most recent round closed in May 2026, raising £211k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 11 | May 2026 | £211k | £0.134 |
| Round 10 | Oct 2025 | £3.8m | £9.00 |
| Round 9 | Dec 2024 | £848k | £0.134 |
| Round 8 | Mar 2024 | £8.3m | £12.50 |
| Round 7 | Mar 2022 | £13.8m | £10.00 |
| Round 6 | Oct 2020 | £11.8m | £7.25 |
Showing the 6 most recent of 11 rounds.
Showing the 10 most recent of 120 filings.
See the complete cap table with every shareholder, founder tags, dilution across 48 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.